UTFacultiesBMSDept TPSHTSRNewsAffordable Anticancer Medicines - Exploring the evidence for sustainable pricing in oncology

Affordable Anticancer Medicines - Exploring the evidence for sustainable pricing in oncology PhD Defence Nora Franzen

On Friday the 15th of July 2022, between 14:30 and 15:30, our colleague Nora Franzen will defend her thesis called "Affordable Anticancer Medicines - Exploring the evidence for sustainable pricing in oncology".

In her dissertation she explores evidenced-based interventions that lead to affordable medicine prices in oncology at market launch in high-income European countries. Affordable prices of innovative anticancer medicines are indispensable in enabling patients to receive the most suitable treatment. The prices of many pharmaceutical treatments are, presumably, leading to healthcare budgets approaching capacity limits globally, including in high-income countries. Anticancer treatments account for the largest cost category in specialized medical care. Strategies are needed to assure the affordability of medicines and sustainability of healthcare systems without compromising pharmaceutical innovation.

You can register for this event via this link. You can also register for the live stream.